Ligand validation:7U9N

CXF: CYCLOHEXYLFORMAMIDE

CXF is a Ligand Of Interest in 7U9N designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7U9N_CXF_A_404	78%	93%	0.135	0.977	0.28	0.2	-	-	0	0	100%	1
7U9N_CXF_C_404	68%	91%	0.147	0.959	0.36	0.2	-	-	1	0	100%	1
7U9N_CXF_B_404	57%	94%	0.168	0.943	0.27	0.18	-	-	3	0	100%	1
7U9N_CXF_D_404	28%	94%	0.235	0.887	0.28	0.16	-	-	0	0	100%	1
8E7U_CXF_A_404	98%	74%	0.06	0.982	0.5	0.51	-	-	1	0	100%	1
8ECS_CXF_B_404	98%	89%	0.054	0.972	0.34	0.29	-	-	2	0	100%	1
7UQ9_CXF_B_404	96%	91%	0.065	0.972	0.28	0.28	-	-	0	0	100%	1
8ECU_CXF_B_404	95%	73%	0.063	0.968	0.4	0.63	-	-	1	0	100%	1
7UTW_CXF_B_404	92%	74%	0.081	0.972	0.33	0.68	-	-	1	0	100%	1
8ECT_CXF_B_404	91%	83%	0.087	0.975	0.34	0.44	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.